BFRI:NASDAQ, Biofrontera Inc.

Why BFRI stock fell on November 5

Biofrontera Inc. fell 10.6% on Thursday, November 5, 2026, on 148,600 shares. The headline around the move:

BFRI stock overview

Biofrontera Inc. (BFRI:NASDAQ) closed at $0.870 on November 9, 2026, up 5.09% on the day. The stock trades 47.6% below its 52-week high of $1.66 and 56.7% above its 52-week low of $0.555. Over the past year, it lost 20.4%. Biofrontera Inc. is part of the Health Care sector.

Key figures

Price
$0.870
Day change
+5.09%
Volume
90,785
Average volume
492,428
Market cap
12M+
52-week range
$0.555 – $1.66
50-day average
$1.09
200-day average
$1.03

Price action over the past year

In 252 trading sessions since November 6, 2025, BFRI closed higher on 117 days (46%). Its best day was January 2, 2026 (+27.19%) and its worst was December 31, 2025 (-20.83%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

BFRI news

About Biofrontera Inc.

Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.

Similar stocks

Find more stocks like BFRI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.